Literature DB >> 2944463

Cirrhotic ascites. Pathophysiology, diagnosis, and management.

V K Rocco, A J Ware.   

Abstract

Cirrhotic ascites occurs via both overflow and underfill mechanisms. Intrahepatic hypertension activates a hepatic baroreceptor reflex that enhances renal sodium absorption; plasma volume is expanded. As cirrhosis progresses, the hepatoportal Starling forces become sufficiently disturbed to sequester this "overflow" in the peritoneal cavity, which results in ascites formation. "Underfill" of the vascular system occurs and eventually dominates the clinical picture. Finally, intrahepatic hypertension also activates the renin-angiotensin system, which causes renal vasoconstriction; the increase in renal prostaglandin synthesis maintains renal blood flow. Although cirrhotic ascites is traditionally classified as a transudate, the serum-ascites albumin gradient may be a better indicator of ascites secondary to portal hypertension than other causes. General management of patients with cirrhotic ascites includes severe restriction of dietary sodium intake and bed rest; diuretics are added if spontaneous diuresis does not occur after 3 to 4 days.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944463     DOI: 10.7326/0003-4819-105-4-573

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

Review 2.  Clinical significance in alcoholic patients of commonly encountered laboratory test results.

Authors:  G J Magarian; L M Lucas; K L Kumar
Journal:  West J Med       Date:  1992-03

3.  Role of the renal nerves in renal sodium retention and edema formation.

Authors:  G F DiBona
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

4.  Abstracts of selected papers presented at the 29th annual meeting of the Japanese Society of Gastroenterology. Kofu, Japan, November 5-7, 1987.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1988-10

5.  Diagnostic utility of the serum-ascites albumin gradient in Mexican patients with ascites related to portal hypertension.

Authors:  Enrique Cervantes Pérez; Gabino Cervantes Guevara; Gabino Cervantes Pérez; Guillermo Alonso Cervantes Cardona; Clotilde Fuentes Orozco; Kevin Josué Pintor Belmontes; Bertha Georgina Guzmán Ramírez; Laura Lizeth Reyes Aguirre; Francisco José Barbosa Camacho; Aldo Bernal Hernández; Alejandro González Ojeda
Journal:  JGH Open       Date:  2020-08-08

6.  Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion.

Authors:  G Decaux; F Prospert; B Namias; M Schlesser; A Soupart
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

7.  Peritoneal Kaposi's sarcoma: a cause of ascites in acquired immunodeficiency syndrome.

Authors:  R Leal; M Lewin; I Ahmad; J Korula
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

8.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

9.  Diagnostic Utility of Serum Ascites Lipid and Protein Gradients in Differentiation of Ascites.

Authors:  Mukhyaprana Prabhu; Rahul Sai Gangula; Weena Stanley
Journal:  Int J Hepatol       Date:  2019-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.